Serum Osteopontin Predicts Degree of Hepatic Fibrosis and Serves as a Biomarker in Patients with Hepatitis C Virus Infection

• Yasuhiro Matsue,

  Affiliation Department of Hepatology, Kanazawa Medical University, Uchinada, Ishikawa, Japan

  ⨯
• Mikihiro Tsutsumi,

  Affiliation Department of Hepatology, Kanazawa Medical University, Uchinada, Ishikawa, Japan

  ⨯
• Nobuhiko Hayashi,

  Affiliation Department of Hepatology, Kanazawa Medical University, Uchinada, Ishikawa, Japan

  ⨯
• Takashi Saito,

  Affiliation Department of Hepatology, Kanazawa Medical University, Uchinada, Ishikawa, Japan

  ⨯
• Mutsumi Tsuchishima,

  Affiliation Department of Hepatology, Kanazawa Medical University, Uchinada, Ishikawa, Japan

  ⨯
• Nobuyuki Toshikuni,

  Affiliation Department of Hepatology, Kanazawa Medical University, Uchinada, Ishikawa, Japan

  ⨯
• Tomiyasu Arisawa,

  Affiliation Department of Gastroenterology, Kanazawa Medical University, Uchinada, Ishikawa, Japan

  ⨯
• Joseph George

  * E-mail: georgej@kanazawa-med.ac.jp

  Affiliation Department of Hepatology, Kanazawa Medical University, Uchinada, Ishikawa, Japan

  ⨯